Question Title

* 1. Please select your designation(s):

Question Title

* 2. Please indicate your specialties:

Question Title

* 3. Please select the categories you most identify with:

Question Title

* 4. Friday, June 27, 8:00-9:30 am
Plenary Session: Non-Coding RNA and Immune Diseases

  Disagree Undecided Agree Did not attend
I will make changes in my practice as a result of what I learned in this session.

Question Title

* 5. After participating in this session, are you able to:

  Yes No
Articulate plausible hypotheses about microRNA regulation of cell differentiation and the mechanisms through which the microRNA(s) act based on examples from the study of helper T cells.
Review the experimental evidence that demonstrates the control of T cell activation and differentiation on the post-transcriptional level.
Discuss the underlying molecular mechanisms and connect the deregulation of those processes to the development of autoimmune and auto-inflammatory diseases.
Discuss the role of inflammation-associated microRNAs in fatty liver disease.
Describe the role of miR-155 in Kupffer cell activation in alcoholic liver disease.
Review the diagnostic and therapeutic potential of circulating miRNAs in liver disease.

Question Title

* 6. Please rate the quality of the presentations:

  Excellent Good Average Poor
Molecular and Cellular Insights into the Phenotypic Spectrum of RAG Deficiency - Luigi Notarangelo, MD
Allergic Pathways in Monogenic Diseases of Atopy - Joshua Milner, MD
Uncovering New Immunoregulatory Mechanisms by Understanding Genetic Diseases - Michael Lenardo, MD

Question Title

* 7. Did you perceive bias in any of the session presentations?

  Yes No
Molecular and Cellular Insights into the Phenotypic Spectrum of RAG Deficiency - Luigi Notarangelo, MD
Allergic Pathways in Monogenic Diseases of Atopy - Joshua Milner, MD
Uncovering New Immunoregulatory Mechanisms by Understanding Genetic Diseases - Michael Lenardo, MD

Question Title

* 8. Friday, June 27,10:00-11:30 am
Plenary Session: Immunologic Lessons of Rare Diseases

  Disagree Undecided Agree Did not attend
I will make changes in my practice/profession as a result of what I learned in this session.

Question Title

* 9. After participating in this session, are you able to:

  Yes No
Recognize the clinical and immunological spectrum of RAG deficiency in humans.
Describe the molecular mechanisms that underlie phenotypic heterogeneity of RAG deficiency.
Recognize specific allergic phenotypes which can be associated with monogenic disease.
Describe contemporary approaches to genomic analysis of inherited disorders of the immune system.
Discuss how specific gene disorders are investigated at the cell biological and immunological levels.

Question Title

* 10. Please rate the quality of the session presentations:

  Excellent Good Average Poor
Molecular and Cellular Insights into the Phenotypic Spectrum of RAG Deficiency - Luigi Notarangelo, MD
Allergic Pathways in Monogenic Diseases of Atopy - Joshua Milner, MD
Uncovering New Immunoregulatory Mechanisms by Understanding Genetic Diseases - Michael Lenardo, MD

Question Title

* 11. Did you perceive bias in any of the session presentations?

  Yes No
Molecular and Cellular Insights into the Phenotypic Spectrum of RAG Deficiency - Luigi Notarangelo, MD
Allergic Pathways in Monogenic Diseases of Atopy - Joshua Milner, MD
Uncovering New Immunoregulatory Mechanisms by Understanding Genetic Diseases - Michael Lenardo, MD

Question Title

* 12. Friday, June 27, 1:00-2:45 pm
Concurrent Thematic Symposium: Germinal RXn in Autoimmunity

  Disagree Undecided Agree Did not attend
I will make changes in my practice/profession as a result of what I learned in this session.

Question Title

* 13. After participating in this session, are you able to:

  Yes No
Describe the importance of Tfh cells in normal immune responses and autoimmune responses.
Discuss the factors involved in Tfh differentiation.
Describe the value of using different technologies to identify gene variants that may explain the pathogenesis of human autoimmunity.
Appreciate the importance of local adaptive immune responses in renal inflammation and current technologies that can be applied to the study of diseased human tissue.

Question Title

* 14. Please rate the quality of the session presentations:

  Excellent Good Average Poor
Differentiation and Function of Follicular Helper T Cells (Tfh) - Shane Crotty, PhD
Tfh Cell Regulation to Prevent Systemic Autoimmunity - Carola Vinuesa, MD, PhD
In situ Adaptive Immunity in the Pathogenesis of Lupus Nephritis - Marcus Clark, MD

Question Title

* 15. Did you perceive bias in any of the session presentations?

  Yes No
Differentiation and Function of Follicular Helper T Cells (Tfh) - Shane Crotty, PhD
Tfh Cell Regulation to Prevent Systemic Autoimmunity - Carola Vinuesa, MD, PhD
In situ Adaptive Immunity in the Pathogenesis of Lupus Nephritis - Marcus Clark, MD

Question Title

* 16. Friday, June 27, 1:00-2:45 pm
Concurrent Thematic Symposium: Challenges in Vaccine Development

  Disagree Undecided Agree Did not attend
I will make changes in my practice/profession as a result of what I learned in this session.

Question Title

* 17. After participating in this session, are you able to:

  Yes No
Describe current concepts in HSV pathogenesis and the viral kinetics of an HSV-2 episode in the immunocompetent host.
Discuss mechanisms of HSV specific T cell function.
Describe the current model of HSV-2 reactivation.
Discuss the problem of developing a vaccine against an organism that triggers autoimmune disease.

Question Title

* 18. Please rate the quality of the session presentations:

  Excellent Good Average Poor
HSV-2: New Concepts in HSV-2 Vaccine Development - Larry Corey, MD
Scientific Development of a Highly Successful Malaria Vaccine - Robert Seder, MD
Vaccines that are Difficult to Develop - Jorge Kalil, MD, PhD

Question Title

* 19. Did you perceive bias in any of the session presentations?

  Yes No
HSV-2: New Concepts in HSV-2 Vaccine Development - Larry Corey, MD
Scientific Development of a Highly Successful Malaria Vaccine - Robert Seder, MD
Vaccines that are Difficult to Develop - Jorge Kalil, MD, PhD

Question Title

* 20. Friday, June 27, 1:00-2:45 pm
Concurrent Thematic Symposium: NK and NKT Cells in Disease

  Disagree Undecided Agree Did not attend
I will make changes to my practice/profession as a result of what I learned in this session.

Question Title

* 21. After participating in this session, are you able to:

  Yes No
Describe what activates NKT cells.
Describe how NKT cell-mediated adjuvant therapy is applicable for all human beings irrespective of MHC polymorphism.
Discuss the mechanisms of NKT cell-mediated adjuvant activity and their clinical efficacy on advanced non-small lung cancer and head and neck cancer.
Describe the consequences of selective deficiency of NK cells in susceptibility to infections.
Explain mechanisms by which NK cells recognize and respond to cytomegalovirus infection.

Question Title

* 22. Please rate the quality of the session presentations:

  Excellent Good Average Poor
Antigen Presentation by CD1d and the Varied Functions of NKT Cells - Mike Brenner, MD
NKT Cell-Mediated Adjuvant Cell Therapy on Lung Cancer and Head and Neck Cancer - Masaru Taniguchi, MD, PhD
Natural Killer Cells and Viral Immunity - Lewis Lanier, PhD

Question Title

* 23. Did you perceive bias in any of the session presentations?

  Yes No
Antigen Presentation by CD1d and the Varied Functions of NKT Cells - Mike Brenner, MD
NKT Cell-Mediated Adjuvant Cell Therapy on Lung Cancer and Head and Neck Cancer - Masaru Taniguchi, MD, PhD
Natural Killer Cells and Viral Immunity - Lewis Lanier, PhD

Question Title

* 24. Friday, June 27, 3:15-5:15 pm
Flow Cytometry for Immune Monitoring Course: Analysis of Intracellular Cytokines and Phosphoproteins

  Disagree Undecided Agree Did not attend
I will make changes in my practice/profession as a result of what I learned in this session.

Question Title

* 25. Please rate the quality of the session presentations:

  Excellent Good Average Poor
Key Variables in Intracellular Cytokine and Phosphoprotein Analysis by Flow Cytometry - Holden Maecker, PhD
Considerations for Rare Cell Analysis in Flow Cytometry - Philip McCoy, PhD

Question Title

* 26. Did you perceive bias in any of the session presentations?

  Yes No
Key Variables in Intracellular Cytokine and Phosphoprotein Analysis by Flow Cytometry - Holden Maecker, PhD
Considerations for Rare Cell Analysis in Flow Cytometry - Philip McCoy, PhD

Question Title

* 27. Friday, June 27, 5:30-6:15 pm
Keynote Address: Engineering T Cells for Cancer and HIV - Carl June, MD

  Disagree Undecided Agree Did not attend
I will make changes in my practice/profession as a result of what I learned in this session.

Question Title

* 28. After participating in this session I am able to :

  Yes No
Describe the concept of adoptive T cell transfer.
Demonstrate familiarity with chimeric antigen receptors.
Recognize potential applications with genetic editing using zinc finger nucleases.

Question Title

* 29. Please rate the quality of this presentation.

Question Title

* 30. Did you perceive bias in this presentation?

Question Title

* 31. If you would like to receive a CME certificate or certificate of attendance, please indicate below.

( Privacy & Cookie Notice

T